Results 311 to 320 of about 1,615,493 (360)
Some of the next articles are maybe not open access.

High-Density Lipoprotein Metabolism

2000
High-density lipoprotein (HDL) cholesterol concentrations are inversely associated with coronary heart disease (CHD) in humans [1,2]. The initial descriptions of this inverse relationship in the early 1950s [3–5] were “rediscovered” in the 1970s [6–9].
openaire   +3 more sources

High-Density Lipoproteins

2007
Low plasma levels of cholesterol carried by high-density lipoprotein (HDL) particles are firmly established as a major cardiovascular risk factor. Paradoxically, cardiovascular mortality is also elevated at extremely high levels of HDL cholesterol. Furthermore, genetic epidemiology often does not support a causal relationship between HDL cholesterol ...
openaire   +2 more sources

Exercise and High-Density Lipoproteins

JAMA: The Journal of the American Medical Association, 1979
Ever since high-density lipoprotein (HDL)-cholesterol, as a measure of the HDLs, was found to be elevated in crosscountry skiers 1 and marathon runners, 2 investigators have debated whether this is a self-selection phenomenon, ie, skinny athletic persons naturally have higher HDL levels and are attracted to long-distance competitive sports because they
openaire   +3 more sources

High Density Lipoproteins in Diabetes

Diabetes, 1981
The concentration of high density lipoproteins (HDL) in patients with diabetes mellitus is highly variable. Subnormal HDL cholesterol levels are present in untreated patients with insulin-deficient juvenile diabetes, but the values return to the normal range after beginning insulin therapy.
openaire   +3 more sources

High Density Lipoproteins in Cholestasis

Scandinavian Journal of Gastroenterology, 1974
Blomhoff, J. P. High density lipoproteins in cholestasis. Scand. J. Gastroent. 1974, 9, 591–596.Two patients with cholestasis with increased concentration of plasma free cholesterol and phospholipi...
openaire   +3 more sources

High-density lipoprotein subclasses

Current Opinion in Lipidology, 1994
This review describes recent advances that have been made in the separation of HDL subfractions by physicochemical and immunological methods and the relationship between the particles obtained by the different procedures. The metabolic interconversions that occur as a result of cholesteryl ester transfer protein (CETP), lecithin:cholesterol ...
openaire   +2 more sources

Modified Low-Density Lipoproteins and High-Density Lipoproteins

Pathophysiology of Haemostasis and Thrombosis, 2006
It has long been known that the oxidative state of the various plasma lipoproteins modulates platelet aggregability, thereby contributing to atherogenesis. Low-density lipoprotein (LDL), occurring in vivo both in the native and oxidised forms, interacts directly with platelets, by binding to specific receptors.
Franz Koller   +3 more
openaire   +2 more sources

Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein

Pathophysiology of Haemostasis and Thrombosis, 2006
Cardiovascular disease is the main cause of death and disability in the Western society. Lipoproteins are important in the development of cardiovascular disease since they change the properties of different cells involved in atherosclerosis and thrombosis. The interaction of platelets with lipoproteins has been under intense investigation. Particularly
Jan-Willem N. Akkerman   +1 more
openaire   +3 more sources

High-Density Lipoprotein Metabolism

1980
Publisher Summary Cholesterol is an essential structural component of all cell membranes. The cholesterol of extrahepatic tissues appears to be derived from receptor-mediated uptake of plasma low-density lipoprotein, to a lesser extent from endogenous synthesis, and also from direct transfer from cholesterol-rich lipoproteins. Most tissues are unable
N. E. Miller, Barry Lewis, A. Nicoll
openaire   +3 more sources

The metabolism of high-density lipoproteins

Trends in Cardiovascular Medicine, 1994
Although high-density lipoproteins (HDLs) have been shown to be the best single indicator of the risk of coronary heart disease (CHD), relatively little is known about their metabolism. Accordingly, only limited strategies are available for therapeutically raising plasma HDL levels.
openaire   +3 more sources

Home - About - Disclaimer - Privacy